Rua Bioscience Ltd.NZX: RUA

RUA: Q1 FY25 sales surged, export channels expanded, and a capital raise is planned for further growth

· Issued by Rua Bioscience Ltd.

Q1 FY25 sales more than doubled FY24's total, driven by export growth in Germany and Australia. Despite going concern uncertainties, operational flexibility and a planned capital raise position the business for continued expansion and entry into the UK market.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.